Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average ...

Clinical supply chains are transforming, and so are the technological barriers to entry for firms in Life Sciences. To stay ...

Precigen’s immunotherapy will likely reduce the need for repeat surgeries in recurrent respiratory papillomatosis (RRP) ...

Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated ...

Aquestive has entered a strategic funding agreement worth $75m with RTW Investments, aimed at supporting the potential launch ...

Sanofi has received orphan designation from the EMA for rilzabrutinib, a reversible covalent BTK inhibitor, to treat IgG4-RD.

Clinical trial data management is growing increasingly complex, with inefficiencies driving up costs and delaying timelines.

Tonix has received approval from the US FDA for Tonmya (cyclobenzaprine HCl sublingual tablets) to treat fibromyalgia in ...

Sanofi's Tzield is now the first and only disease-modifying therapy to be approved for type 1 diabetes (T1D) in the UK.

The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.

According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six people in the US.